PQ 3782
3782. Deputy Paul McAuliffe asked the Minister for Health the measures being taken to ensure that Ireland’s commitments under the National Rare Disease Strategy translate into timely access to innovative medicines for people living with rare diseases. [62887/26]
Introduced
7 September 2026
Last action
7 September 2026 · Clinical Trials
Status
written
Sponsors
Paul McAuliffe
Subjects
Discovery layer
Source updated
7 September 2026
Summary
3782. Deputy Paul McAuliffe asked the Minister for Health the measures being taken to ensure that Ireland’s commitments under the National Rare Disease Strategy translate into timely access to innovative medicines for people living with rare diseases. [62887/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 September 2026
Clinical Trials
3782. Deputy Paul McAuliffe asked the Minister for Health the measures being taken to ensure that Ireland’s commitments under the National Rare Disease Strategy translate into timely access to innovative medicines for people living with rare diseases. [62887/26]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Clinical Trials
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Clinical Trials
xml · EN · 7 September 2026
Sponsors
- Paul McAuliffe · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-09-07/3782/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-09-07/pq_3782
- ireland · q-2026-09-07-pq_3782 · source updated 7 September 2026